The application of immunohistochemistry to detect the products of RCC predisposition genes (e.g. SDHB, FH/2SC, BAP1, etc.)can aid interpretation of equivocal genetic findings, and in vitro and in vivo metabolomic studies may have a role in specific cases. Here, BAP1 is linked to renal cell carcinoma.